# Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease

> **NCT02405598** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 14 (actual)

## Conditions studied

- Pompe Disease

## Interventions

- **DRUG:** Salbutamol

## Key facts

- **NCT ID:** NCT02405598
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-07
- **Final completion:** 2016-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02405598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02405598, "Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02405598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*